Amphiregulin in Cancer: New Insights for Translational Medicine.

Although there is a large body of literature regarding amphiregulin (AREG) in human cancer, most knowledge focuses on its cell-autonomous functions in epithelial malignancies. Recent studies revealed that AREG is also present in the tumor microenvironment (TME) and contributes to therapeutic resistance. We discuss emerging concepts of AREG tumor biology and highlight their implications for translational medicine.

[1]  P. Nelson,et al.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation , 2015, Nature Cell Biology.

[2]  Xi Chen,et al.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. , 2014, Cancer research.

[3]  A. Rudensky,et al.  A Distinct Function of Regulatory T Cells in Tissue Protection , 2015, Cell.

[4]  D. Hawke,et al.  Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation , 2015, Nature Cell Biology.

[5]  S. Stewart,et al.  p38MAPK plays a crucial role in stromal-mediated tumorigenesis. , 2014, Cancer discovery.

[6]  Li-juan Wang,et al.  Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma , 2014, Journal of immunology research.

[7]  G. Mills,et al.  An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors , 2016, Oncogene.

[8]  R. Kitsis,et al.  MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype. , 2015, Molecular cell.

[9]  P. Coffer,et al.  Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. , 2013, Immunity.

[10]  N. Sharpless,et al.  Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice , 2015, Nature Medicine.

[11]  Qikai Xu,et al.  The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4 , 2015, Science.

[12]  S. Ethier,et al.  Oncogenic signaling in amphiregulin and EGFR‐expressing PTEN‐null human breast cancer , 2014, Molecular oncology.

[13]  D. Marshak,et al.  Stem Cell Biology , 2001 .

[14]  Judith Campisi,et al.  Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B , 2012, Nature Medicine.

[15]  D. Jodrell,et al.  Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo , 2012, PloS one.

[16]  Jianqing Xu,et al.  SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment , 2016, Oncogene.

[17]  W. Gause,et al.  Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. , 2015, Immunity.